Trial Profile
Effects of pradigastat on the pharmacokinetics of a combination oral contraceptive in healthy female subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Hyperlipoproteinaemia type I
- Focus Pharmacokinetics
- Sponsors Novartis
- 28 Oct 2015 New trial record